Cerus (CERS) EBITDA Margin Growth (3y) (2013 - 2026)
Cerus (CERS) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | -184.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -763.00 |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 10,018.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,018.00 |
| Dec 31, 2025 | 484.00 |
| Sep 30, 2025 | 12,636.00 |
| Jun 30, 2025 | -60,911.00 |
| Mar 31, 2025 | 5,300.00 |
| Dec 31, 2024 | 407.00 |
| Sep 30, 2024 | 4,829.00 |
| Jun 30, 2024 | 8,558.00 |
| Mar 31, 2024 | 14,939.00 |
| Dec 31, 2023 | 1,590.00 |
| Sep 30, 2023 | -72,250.00 |
| Jun 30, 2023 | 7,105.00 |
| Mar 31, 2023 | 480,425.00 |
| Dec 31, 2022 | 28,919.00 |
| Sep 30, 2022 | 391,806.00 |
| Jun 30, 2022 | 37,698.00 |
| Mar 31, 2022 | 28,653.00 |
| Dec 31, 2021 | 8,745.00 |
| Sep 30, 2021 | -9,802.00 |
| Jun 30, 2021 | 21,230.00 |